Article Details
Retrieved on: 2018-01-09 17:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>As previously reported on the Current Report on Form 8-K of Anthera Pharmaceuticals, Inc. (the “Company”) filed on October 25, 2017 (the “October 25 8-K”), the Company entered into a <b>Securities</b> Purchase Agreements (the “<b>Securities</b> Purchase Agreement”) on October 23, 2017 for a private placement ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here